All Stories

  1. Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects

    Article • PLoS ONE, August 2019, PLOS

    Dr Pawel Wiczling

  2. Ionization of tocopherols and tocotrienols in atmospheric pressure chemical ionization

    Article • Rapid Communications in Mass Spectrometry, May 2018, Wiley

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  3. Evaluation of sequential Bayesian-based method development procedures for chromatographic problems involving one, two, and three analytes

    Article • Separation Science Plus, January 2018, Wiley

    Dr Pawel Wiczling

  4. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock

    Article • Antimicrobial Agents and Chemotherapy, January 2018, ASM Journals

    Dr Pawel Wiczling

  5. Hydroxycarbamide in children with sickle cell anaemia after first-dose vs . chronic therapy: pharmacokinetics and predictive models for drug exposure

    Article • British Journal of Clinical Pharmacology, November 2017, Wiley

    Dr Pawel Wiczling

  6. How to model temporal changes in non-targeted metabolomics study? A Bayesian multilevel perspective

    Article • Journal of Separation Science, October 2017, Wiley

    Dr Pawel Wiczling, Dr Roman Kaliszan, Professor Michal J Markuszewski

  7. Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants

    Article • The Journal of Clinical Pharmacology, May 2017, Wiley

    Dr Pawel Wiczling, Agnieszka Bienert

  8. The pharmacokinetics of propofol in ICU patients undergoing long-term sedation

    Article • Biopharmaceutics & Drug Disposition, September 2016, Wiley

    Dr Pawel Wiczling

  9. Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients

    Article • The Journal of Clinical Pharmacology, August 2015, Wiley

    Dr Pawel Wiczling

  10. Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery

    Article • Journal of Pharmacokinetics and Pharmacodynamics, January 2015, Springer Science + Business Media

    Dr Pawel Wiczling

  11. Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled-infusions

    Article • The Journal of Clinical Pharmacology, October 2014, Wiley

    Dr Pawel Wiczling, Agnieszka Bienert

  12. Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries

    Article • Pharmacological Reports, October 2014, Elsevier

    Dr Pawel Wiczling

  13. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats

    Article • Biopharmaceutics & Drug Disposition, June 2014, Wiley

    Dr Pawel Wiczling

  14. The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography–mass spectrometry

    Article • Journal of Pharmaceutical and Biomedical Analysis, June 2014, Elsevier

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  15. Development and validation of UHPLC method for the determination of cyclosporine A in biological samples

    Article • Biomedical Chromatography, May 2014, Wiley

    Dr Pawel Wiczling, Dr Roman Kaliszan, Professor Michal J Markuszewski

  16. Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease

    Article • The Journal of Clinical Pharmacology, April 2014, Wiley

    Dr Pawel Wiczling

  17. The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits

    Article • Pharmacological Reports, February 2014, Elsevier

    Dr Pawel Wiczling

  18. Determination of red blood cell age distribution by means of capillary electrophoresis

    Article • Pharmacological Reports, May 2013, Elsevier

    Dr Pawel Wiczling

  19. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children

    Article • Pharmacological Reports, January 2013, Elsevier

    Dr Pawel Wiczling

  20. New supervised alignment method as a preprocessing tool for chromatographic data in metabolomic studies

    Article • Journal of Chromatography A, September 2012, Elsevier

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  21. A new pH/organic modifier gradient RP HPLC method for convenient determination of lipophilicity and acidity of drugs as applied to established imidazoline agents

    Article • European Journal of Pharmaceutical Sciences, August 2012, Elsevier

    Dr Pawel Wiczling

  22. Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics

    Article • Pharmacological Reports, July 2012, Elsevier

    Dr Pawel Wiczling

  23. QSAR, QSPR and QSRR in Terms of 3-D-MoRSE Descriptors for In Silico Screening of Clofibric Acid Analogues

    Article • Molecular Informatics, June 2012, Wiley

    Dr Pawel Wiczling

  24. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I–III patients

    Article • Arzneimittelforschung, February 2012, Thieme Publishing Group

    Dr Pawel Wiczling

  25. Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery

    Article • Pharmacological Reports, January 2012, Elsevier

    Dr Pawel Wiczling

  26. Gradient reversed-phase high-performance chromatography of ionogenic analytes

    Article • TrAC Trends in Analytical Chemistry, October 2011, Elsevier

    Dr Pawel Wiczling

  27. Thermodynamic vs. extrathermodynamic modeling of chromatographic retention

    Article • Journal of Chromatography A, August 2011, Elsevier

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  28. Influence of Time of Day on Propofol Pharmacokinetics and Pharmacodynamics in Rabbits

    Article • Chronobiology International, May 2011, Taylor & Francis

    Dr Pawel Wiczling

  29. Reversed-Phase TLC and HPLC Retention Data in Correlation Studies with in Silico Molecular Descriptors and Druglikeness Properties of Newly Synthesized Anticonvulsant Succinimide Derivatives

    Article • Molecular Pharmaceutics, April 2011, American Chemical Society (ACS)

    Dr Pawel Wiczling

  30. Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes

    Article • The Journal of Clinical Pharmacology, November 2010, Wiley

    Dr Pawel Wiczling

  31. Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations

    Article • The Journal of Clinical Pharmacology, September 2010, Wiley

    Dr Pawel Wiczling

  32. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients

    Article • Journal of Pharmacokinetics and Pharmacodynamics, June 2010, Springer Science + Business Media

    Dr Pawel Wiczling, dr Miłosz J. Regulski

  33. pH Gradient as a Tool for the Separation of Ionizable Analytes in Reversed-Phase High-Performance Chromatography

    Article • Analytical Chemistry, May 2010, American Chemical Society (ACS)

    Dr Pawel Wiczling

  34. Retention time and peak width in the combined pH/organic modifier gradient high performance liquid chromatography

    Article • Journal of Chromatography A, May 2010, Elsevier

    Dr Pawel Wiczling

  35. Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus

    Article • The Journal of Clinical Pharmacology, May 2010, Wiley

    Dr Pawel Wiczling

  36. Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults following Intravenous and Subcutaneous Administrations

    Article • Clinical Pharmacokinetics, December 2009, Springer Science + Business Media

    Dr Pawel Wiczling

  37. Flow cytometric analysis of reticulocyte maturation after erythropoietin administration in rats

    Article • Cytometry Part A, July 2009, Wiley

    Dr Pawel Wiczling

  38. The application of gradient reversed-phase high-performance liquid chromatography to the pKa and determination of polyprotic analytes

    Article • Journal of Chromatography A, December 2008, Elsevier

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  39. Influence of pH on Retention in Linear Organic Modifier Gradient RP HPLC

    Article • Analytical Chemistry, October 2008, American Chemical Society (ACS)

    Dr Pawel Wiczling

  40. Flow cytometric assessment of homeostatic aging of reticulocytes in rats

    Article • Experimental Hematology, February 2008, Elsevier

    Dr Pawel Wiczling

  41. Method of determination of the reticulocyte age distribution from flow cytometry count by a structured-population model

    Article • Cytometry Part A, January 2007, Wiley

    Dr Pawel Wiczling

  42. Double gradient of organic modifier nad pKa in RP HPLC

    Article • Analytical Chemistry, January 2006, American Chemical Society (ACS)

    Dr Pawel Wiczling, Dr Piotr Kawczak

  43. Verification of the exponential model of body temperature decrease after death in pigs

    Article • Experimental Physiology, September 2005, Wiley

    Dr Pawel Wiczling

  44. Prediction of Peptide Retention at Different HPLC Conditions from Multiple Linear Regression Models

    Article • Journal of Proteome Research, April 2005, American Chemical Society (ACS)

    Dr Pawel Wiczling

  45. Combined pH/organic solvent gradient HPLC in analysis of forensic material

    Article • Journal of Pharmaceutical and Biomedical Analysis, April 2005, Elsevier

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  46. Theoretical opportunities and actual limitations of pH gradient HPLC

    Article • Analytical and Bioanalytical Chemistry, February 2005, Springer Science + Business Media

    Dr Pawel Wiczling

  47. pH/Organic Solvent Double-Gradient Reversed-Phase HPLC

    Article • Analytical Chemistry, January 2005, American Chemical Society (ACS)

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  48. pH gradient high-performance liquid chromatography: theory and applications

    Article • Journal of Chromatography A, December 2004, Elsevier

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  49. High-throughput Evaluation of Lipophilicity and Acidity by New Gradient HPLC Methods

    Article • Combinatorial Chemistry & High Throughput Screening, June 2004, Bentham Science Publishers

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  50. Determination of pKaby pH Gradient Reversed-Phase HPLC

    Article • Analytical Chemistry, June 2004, American Chemical Society (ACS)

    Dr Pawel Wiczling, Professor Michal J Markuszewski

  51. pH Gradient Reversed-Phase HPLC

    Article • Analytical Chemistry, February 2004, American Chemical Society (ACS)

    Dr Pawel Wiczling, Professor Michal J Markuszewski